Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RAREHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 14.89 0.00%
RARE stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.47B
- Forward P/E
- 22.00
- EPS (TTM)
- -$5.82
- Dividend yield
- None
- 52-week range
- 12.73 – 39.89
- Day range
- 14.35 – 15.25
- Volume / Avg
- 4.16M / 3.79M
- Beta
- —
- Shares outstanding
- 98.59M
- Next earnings
- Nov 3, 2026
52-week range
RARE stock today
On Oct 7, RARE ended the session at $14.89, adding $0.43 (2.97%), versus the S&P 500's 0.22% decline. At this level, RARE sits near the bottom of its 52-week range of $12.73 to $39.89: 62.7% below the high, set on Dec 8, 2025 and 17.0% above the low. RARE is down 35.3% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 49.9%.
Ultragenyx Pharmaceutical has posted a net loss over the last twelve months (EPS of -$5.82), so its P/E ratio is not meaningful. Ultragenyx Pharmaceutical's next earnings report is expected on Nov 3, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Ultragenyx Pharmaceutical
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2014
Earnings
Earnings history- Next report
- Nov 3, 2026
- EPS estimate
- $-0.65
RARE news
All RARE newsUltragenyx Pharmaceutical peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| KRSAKorsana Biosciences Inc. | 31.65 | -0.38% | $1.44B | vs RARE |
| GHRSGH Research PLC | 21.06 | -2.14% | $1.45B | vs RARE |
| TYRATyra Biosciences Inc. | 20.39 | +0.74% | $1.40B | vs RARE |
| AAPGAscentage Pharma Group International American Depository Shares | 14.94 | -7.15% | $1.40B | vs RARE |
| NKTRNektar Therapeutics | 40.26 | +0.88% | $1.37B | vs RARE |
| RAPPRapport Therapeutics Inc. | 30.86 | -0.93% | $1.48B | vs RARE |
| KLRAKailera Therapeutics Inc. | 10.53 | -2.77% | $1.37B | vs RARE |
| ANABAnaptysBio Inc. | 45.65 | -4.68% | $1.36B | vs RARE |
Indexes, lists and sector
Largest Health Care stocks
Ultragenyx Pharmaceutical stock FAQ
What is Ultragenyx Pharmaceutical's stock price today?
RARE last traded at $14.89 as of Oct 7, 4:00 PM EDT, up 2.97% on the day. Prices are delayed at least 15 minutes.
When is Ultragenyx Pharmaceutical's next earnings date?
Ultragenyx Pharmaceutical is expected to report earnings on Tuesday, November 3, 2026. Analysts expect EPS of $-0.65.
What is the RARE 52-week high?
The 52-week high for RARE is $39.89 and the 52-week low is $12.73. The stock is currently 62.7% below its high.